CN100447126C - 用作抗高血糖剂的ω-取代的萘氧基氨基烷烃衍生物及其制备 - Google Patents

用作抗高血糖剂的ω-取代的萘氧基氨基烷烃衍生物及其制备 Download PDF

Info

Publication number
CN100447126C
CN100447126C CNB2003801107237A CN200380110723A CN100447126C CN 100447126 C CN100447126 C CN 100447126C CN B2003801107237 A CNB2003801107237 A CN B2003801107237A CN 200380110723 A CN200380110723 A CN 200380110723A CN 100447126 C CN100447126 C CN 100447126C
Authority
CN
China
Prior art keywords
methoxy
phenyl
benzyl
ethyl
styroyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2003801107237A
Other languages
English (en)
Chinese (zh)
Other versions
CN1894200A (zh
Inventor
提达特·查图维笛
阿图尔·库马尔
瑞玛·拉斯托吉
阿瑞文德·斯瑞瓦斯塔瓦
佩里蒂·特瓦瑞
里翰·艾哈迈德
拉麦什·钱德
安居·普里
葛提卡·巴蒂亚
法哈尔·里维兹
阿尼尔·库马尔·拉斯托吉
苏卜拉哈特·雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of CN1894200A publication Critical patent/CN1894200A/zh
Application granted granted Critical
Publication of CN100447126C publication Critical patent/CN100447126C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB2003801107237A 2003-10-31 2003-10-31 用作抗高血糖剂的ω-取代的萘氧基氨基烷烃衍生物及其制备 Expired - Fee Related CN100447126C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2003/004853 WO2005042465A1 (en) 2003-10-31 2003-10-31 Omega-substituted-naphthyloxyalklamino derivatives as antihyperglycemic agents and preparation

Publications (2)

Publication Number Publication Date
CN1894200A CN1894200A (zh) 2007-01-10
CN100447126C true CN100447126C (zh) 2008-12-31

Family

ID=34531839

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003801107237A Expired - Fee Related CN100447126C (zh) 2003-10-31 2003-10-31 用作抗高血糖剂的ω-取代的萘氧基氨基烷烃衍生物及其制备

Country Status (4)

Country Link
EP (1) EP1682484A1 (de)
CN (1) CN100447126C (de)
AU (1) AU2003276500A1 (de)
WO (1) WO2005042465A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6931456B2 (ja) * 2017-04-03 2021-09-08 川崎化成工業株式会社 ２−ハロアルコキシ−６−置換オキシナフタレン化合物及び２−ハロアルコキシ−６−置換オキシナフタレン化合物を含有する光重合増感剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260816A (en) * 1975-12-09 1981-04-07 American Cyanamid Company Naphthyloxyalkylaminobenzoic acids, salts and esters thereof
JPH03209350A (ja) * 1990-01-10 1991-09-12 Mitsubishi Gas Chem Co Inc ナフトキシエチルアミン類および農園芸用殺菌剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235597A (en) * 1963-08-12 1966-02-15 Lilly Co Eli N-aryloxyalkyl and arylthioalkyl derivatives of cyclopropylamine
GB1546238A (en) * 1976-04-07 1979-05-23 Serdex Soc D Etudes De Rech De Piperazine derivatives a process for their preparation and their applications
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
CA2206997A1 (en) * 1996-07-10 1998-01-10 Eli Lilly And Company Benzothiophene compounds and methods of use
AU2321000A (en) * 1999-01-29 2000-08-18 Sumitomo Chemical Company, Limited Fat accumulation inhibitory agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260816A (en) * 1975-12-09 1981-04-07 American Cyanamid Company Naphthyloxyalkylaminobenzoic acids, salts and esters thereof
JPH03209350A (ja) * 1990-01-10 1991-09-12 Mitsubishi Gas Chem Co Inc ナフトキシエチルアミン類および農園芸用殺菌剤

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
acetylcholinesterase inhibitors:SAR and kinetic studies on ω－[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives, .. Angela Rampa,et al.J.med. chem.,Vol.44 . 2001
acetylcholinesterase inhibitors:SAR and kinetic studies on ω－[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives,. Angela Rampa,et al.J.med. chem.,Vol.44. 2001 *
reaction of the chemical structure of amino ethers to theirpharmacological action,. Acta pharm. Hung.,Vol.33 No.4. 1963
reaction of the chemical structure of amino ethers to theirpharmacological action,. Acta pharm. Hung.,Vol.33 No.4. 1963 *
the syntheseis of some tertiary naphthoxyethylamines,. Robert M.et al.journal of organic chemistry,,Vol.17 . 1952
the syntheseis of some tertiary naphthoxyethylamines,. Robert M.et al.journal of organic chemistry,Vol.17. 1952 *
US－4260816A 1981.04.07

Also Published As

Publication number Publication date
WO2005042465A1 (en) 2005-05-12
AU2003276500A1 (en) 2005-05-19
CN1894200A (zh) 2007-01-10
EP1682484A1 (de) 2006-07-26

Similar Documents

Publication Publication Date Title
CA2029703C (en) Oxazolidinedione hypoglycemic agents
FI89356C (fi) Foerfarande foer framstaellnig av blodsockerhalten saenkande samt atherosklerosis hindrande tiazolidindioner
KR100954237B1 (ko) 퍼록시솜 증식자 활성화 수용체 델타 리간드 티아졸 화합물및 이를 함유하는 의약, 화장품 및 건강식품 조성물
EP1633340B1 (de) Verbindungen zur behandlung von stoffwechselstörungen
KR900005518B1 (ko) 퓨로-(3,4-c)-피리딘 유도체의 제조방법
US5498621A (en) Oxazolidinedione hypoglycemic agents
EP1618086B1 (de) Verbindungen zur behandlung von stoffwechselstörungen
EA015606B1 (ru) Способ лечения связанного с глюкозой расстройства
BG104602A (bg) Производни на арилтиазолидиндион
RU2349584C2 (ru) Соединения для лечения метаболических нарушений
MX2009001104A (es) Derivados de 4-trimetilamonio-3-aminobutirato y 4-trimetilfosfonio-3-aminobutirato como inhibidores de carnitina palmitoil transferasa.
CN100447126C (zh) 用作抗高血糖剂的ω-取代的萘氧基氨基烷烃衍生物及其制备
WO2010006496A1 (zh) 用作雌激素相关受体调节剂的化合物及其应用
US6399658B1 (en) Composition containing ascorbic acid
JPH0231705B2 (de)
PT100711B (pt) Tiazolidinadionas hipoglicemicas e compostos intermediarios
US20050119298A1 (en) Enantiomer (-) of tenatoprazole and the therapeutic use thereof
CN1358096A (zh) 糖尿病治疗剂
IL88513A (en) D5-1-]) 2-benzyl-3,4-dihydro-H-2 benzopyran-6-yl (methyl [thiazolidine-2,4-deion as a medicinal preparation against atherosclerosis
US6531461B1 (en) Medicament for the treatment of diabetes
EP0593348A1 (de) Thiazolidine dione-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
PT100616B (pt) Agentes hipoglicemicos de tiazolinodiona
JPH0358923A (ja) 真性糖尿病の処置法
US20040192688A1 (en) Alpha-substituted naphthyloxy omega-substituted alkyl/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders
CN111153895B (zh) 一种山荷叶素及其在制备预防或治疗糖尿病药物中的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081231

Termination date: 20091130